Jose Manuel Vidal Taboada obtained his PhD in 2000 for his work in the Department of Molecular Biology of Reproduction and Development at the University of Barcelona, Spain. He has held various positions working in the field of genetics and pharmacogenetics. He held a Professor position Faculty of Medicine, University of Barcelona. Currently, he works as main researcher at the Peripheral Nervous System Research Group. Vall d´Hebron Research Institut (VHIR). Vall d’Hebron Barcelona Hospital Campus. Barcelona, Spain. Its current area of occupancy covers the identification of new genetic biomarkers, pharmacogenetics biomarkers and therapeutic targets for Amiotrophic Lateral Sclerosis (ALS), Parkinson's and other neurodegenerative diseases.
Jose Manuel Vidal Taboada obtained his PhD in 2000 for his work in the Department of Molecular Biology of Reproduction and Development at the University of Barcelona, Spain. He has held various positions working in the field of genetics and pharmacogenetics. He held a Professor position Faculty of Medicine, University of Barcelona. Currently, he works as main researcher at the Peripheral Nervous System Research Group. Vall d´Hebron Research Institut (VHIR). Vall d’Hebron Barcelona Hospital Campus. Barcelona, Spain. Its current area of occupancy covers the identification of new genetic biomarkers, pharmacogenetics biomarkers and therapeutic targets for Amiotrophic Lateral Sclerosis (ALS), Parkinson's and other neurodegenerative diseases.